DD283772A5 - Verfahren zur herstellung von enantiomeren glutaramid-verbindungen, die diuretisch wirken - Google Patents

Verfahren zur herstellung von enantiomeren glutaramid-verbindungen, die diuretisch wirken Download PDF

Info

Publication number
DD283772A5
DD283772A5 DD89328675A DD32867589A DD283772A5 DD 283772 A5 DD283772 A5 DD 283772A5 DD 89328675 A DD89328675 A DD 89328675A DD 32867589 A DD32867589 A DD 32867589A DD 283772 A5 DD283772 A5 DD 283772A5
Authority
DD
German Democratic Republic
Prior art keywords
ethyl
formula
compound
benzyl
och
Prior art date
Application number
DD89328675A
Other languages
German (de)
English (en)
Inventor
John Ch Danilewicz
Michael T Williams
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD283772A5 publication Critical patent/DD283772A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD89328675A 1988-05-19 1989-05-17 Verfahren zur herstellung von enantiomeren glutaramid-verbindungen, die diuretisch wirken DD283772A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (1)

Publication Number Publication Date
DD283772A5 true DD283772A5 (de) 1990-10-24

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89328675A DD283772A5 (de) 1988-05-19 1989-05-17 Verfahren zur herstellung von enantiomeren glutaramid-verbindungen, die diuretisch wirken

Country Status (29)

Country Link
EP (1) EP0342850B1 (hu)
JP (1) JPH072699B2 (hu)
KR (1) KR920000561B1 (hu)
CN (1) CN1015361B (hu)
AT (1) ATE76399T1 (hu)
AU (1) AU602813B2 (hu)
CA (1) CA1331197C (hu)
CS (1) CS274502B2 (hu)
DD (1) DD283772A5 (hu)
DE (1) DE68901582D1 (hu)
DK (1) DK172032B1 (hu)
EG (1) EG19007A (hu)
ES (1) ES2037418T3 (hu)
FI (1) FI93541C (hu)
GB (1) GB8811873D0 (hu)
GR (1) GR3004968T3 (hu)
HU (1) HU205067B (hu)
IE (1) IE60724B1 (hu)
IL (1) IL90267A (hu)
MX (1) MX16067A (hu)
MY (1) MY104735A (hu)
NO (1) NO173647C (hu)
NZ (1) NZ229186A (hu)
PH (1) PH26740A (hu)
PL (1) PL154813B1 (hu)
PT (1) PT90584B (hu)
SU (1) SU1766251A3 (hu)
YU (1) YU47973B (hu)
ZA (1) ZA893696B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
DK0644176T3 (da) * 1993-09-22 1996-02-26 Pfizer Ltd Hydrogenering
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
SI2887961T1 (sl) 2012-08-24 2021-08-31 Novartis Ag Zaviralci NEP za zdravljenje bolezni, značilnih po atrialni širitvi ali preoblikovanju
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en) 2015-10-29 2018-11-01 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
KR920000561B1 (ko) 1992-01-16
CN1015361B (zh) 1992-02-05
IL90267A (en) 1993-08-18
GB8811873D0 (en) 1988-06-22
JPH0222256A (ja) 1990-01-25
CA1331197C (en) 1994-08-02
DK240889D0 (da) 1989-05-18
DE68901582D1 (de) 1992-06-25
NO892002D0 (no) 1989-05-18
PH26740A (en) 1992-09-28
CN1037704A (zh) 1989-12-06
NO173647B (no) 1993-10-04
AU3490489A (en) 1989-11-23
ATE76399T1 (de) 1992-06-15
NZ229186A (en) 1990-10-26
EP0342850A1 (en) 1989-11-23
FI892386A0 (fi) 1989-05-18
NO173647C (no) 1994-01-12
JPH072699B2 (ja) 1995-01-18
YU47973B (sh) 1996-08-13
GR3004968T3 (hu) 1993-04-28
MX16067A (es) 1993-10-01
EG19007A (en) 1994-11-30
MY104735A (en) 1994-05-31
IE60724B1 (en) 1994-08-10
FI892386A (fi) 1989-11-20
HUT53596A (en) 1990-11-28
FI93541B (fi) 1995-01-13
DK240889A (da) 1989-11-20
DK172032B1 (da) 1997-09-22
PT90584B (pt) 1994-09-30
SU1766251A3 (ru) 1992-09-30
YU102289A (en) 1991-06-30
CS274502B2 (en) 1991-04-11
ZA893696B (en) 1990-12-28
EP0342850B1 (en) 1992-05-20
ES2037418T3 (es) 1993-06-16
PL279491A1 (en) 1989-11-27
IL90267A0 (en) 1989-12-15
KR900017993A (ko) 1990-12-20
FI93541C (fi) 1995-04-25
AU602813B2 (en) 1990-10-25
IE891613L (en) 1989-11-19
PL154813B1 (en) 1991-09-30
PT90584A (pt) 1989-11-30
HU205067B (en) 1992-03-30
NO892002L (no) 1989-11-20
CS296589A2 (en) 1990-09-12

Similar Documents

Publication Publication Date Title
DD283772A5 (de) Verfahren zur herstellung von enantiomeren glutaramid-verbindungen, die diuretisch wirken
EP0712388A1 (de) Verwendung von phenolen und phenolderivaten als arzneimittel mit fibrinogensenkender wirkung
DE68912811T2 (de) Amide von Cyclomethylen-1,2 bicarbonsäure mit therapeutischer Wirkung, Verfahren zu deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
DE60008160T2 (de) Enantiomerisch reine Reagenzien und Verfahren zur Trennung von Enantiomeren
CH653996A5 (de) Tryptaminderivate und verfahren zu deren herstellung.
DE3872100T2 (de) Verfahren zur herstellung von phenylaethanolaminotetralinen.
CH619468A5 (hu)
DE69100897T2 (de) N-phenyl-n-alkoxycarbonylalkyl-glycinamide, ihre herstellung und sie enthaltende medikamente.
DE69303333T2 (de) Substituierte Benzoate-Derivate
EP0385423B1 (de) Verfahren zur Herstellung der optischen Isomeren von 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure-ethyl-ester und 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure- 2-(N-methyl-N-phenylmethylamino)ethyl ester
DE3874166T2 (de) Verfahren zum herstellen und isolieren von estern der (r)-2-hydroxyphenylbuttersaeure.
EP0511558B1 (de) Racemat-Spaltverfahren und diastereomere Assoziate
EP0170775B2 (de) Derivate bicyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung sowie neue bicyclische Aminosäuren als Zwischenstufen und Verfahren zu deren Herstellung
EP0416583B1 (de) Verfahren zur Herstellung von Crotonobetainhydrochlorid
AT350517B (de) Verfahren zur herstellung von neuen alkylthio- cyclopentanderivaten
EP0154886A2 (de) Carboxyalkyldipeptidderivate, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung
DE2604560A1 (de) Phenylalkancarbonsaeure-derivate und verfahren zu ihrer herstellung
DE1812979C (de) Aminomethylbicyclo oktan und nonan carbonsaure Verbindungen und Verfahren zu ihrer Herstellung
CH651017A5 (de) Verfahren zur herstellung von amiden, peptiden, penicillinen und cephalosporinen.
AT401931B (de) Verfahren zur herstellung von (s,s)-(n-(1- ethoxycarbonyl-3-oxo-3-phenylpropyl)-alanin)- (phenylmethyl)ester
DE4011171A1 (de) Herstellung von (alpha)-aminosaeure-2,2,2,-trifluorethylester
DE3811256A1 (de) (alpha)-trifluormethylaminosaeure-derivate, verfahren zur herstellung von (alpha)-trifluormethylaminosaeure-derivaten und ihre verwendung als arzneimittel
DE3608083A1 (de) Verfahren zur herstellung von peptiden
DE1060380B (de) Verfahren zur Herstellung von Carbonsaeureamiden aus Carbonsaeureestern und Aminen
CH648298A5 (de) 16-amino-prostaglandinderivate und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee